| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Director
2 companies
Chess Robert is a Director at NEKTAR THERAPEUTICS with holdings across 2 companies. Recent SEC Form 4 filings include 0 buys and 11 sells.
Estimated insider holdings value: $16.5M based on current market prices.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Apr 6, 2018 | NKTR Nektar Therapeutics | Director | Sale+OE | 25,000 | $92.14 | $2,303,600.00 | -4.4% | |
| Sep 21, 2017 | NKTR Nektar Therapeutics | Director | Sell | 6,400 | $21.72 | $139,008.00 | -2.3% | |
| May 15, 2017 | NKTR Nektar Therapeutics | Director | Sale+OE | 5,000 | $19.79 | $98,950.00 | -1.8% | |
| Apr 17, 2017 | NKTR Nektar Therapeutics | Director | Sale+OE | 5,000 | $18.72 | $93,600.00 | -1.8% | |
| Mar 14, 2017 | NKTR Nektar Therapeutics | Director | Sale+OE | 5,000 | $15.41 | $77,050.00 | -1.8% | |
| Sep 15, 2016 | NKTR Nektar Therapeutics | Director | Sale+OE | 12,000 | $19.21 | $230,520.00 | -4.6% | |
| Aug 1, 2016 | NKTR Nektar Therapeutics | Director | Sale+OE | 5,000 | $17.26 | $86,300.00 | -1.9% | |
| Jul 1, 2016 | NKTR Nektar Therapeutics | Director | Sale+OE | 5,000 | $14.10 | $70,500.00 | -1.9% | |
| Jun 1, 2016 | NKTR Nektar Therapeutics | Director | Sale+OE | 5,000 | $15.50 | $77,500.00 | -1.9% | |
| Jun 19, 2015 | NKTR Nektar Therapeutics | Director | Sale+OE | 15,000 | $11.81 | $177,150.00 | -5.4% |